Cyra 20mg Tablet
Marketer
Systopic Laboratories Pvt Ltd
Salt Composition
Rabeprazole (20mg)
Overview Cyra 20mg Tablet
Gastro-acid reducer, Cyra 20mg tablets, diminishes stomach acid production. Indicated for gastrointestinal conditions like acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, it alleviates symptoms and facilitates healing. Administer one tablet, ideally in the morning, an hour prior to meals. Dosage is condition- and response-dependent; maintain consistent daily timing as directed. Continue therapy as prescribed, even with rapid symptom resolution. Dietary modifications, such as smaller, more frequent meals, and avoidance of caffeine, spicy, and fatty foods may further benefit symptom management. Common, generally mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and abdominal discomfort. Report persistent or bothersome effects to your physician. Prolonged use (over one year), particularly at higher doses, may elevate fracture risk. Discuss bone health strategies, including calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) can occur after three or more months of use, manifesting as fatigue, confusion, dizziness, muscle spasms, and arrhythmia. Your physician may monitor magnesium levels. Cyra 20mg is contraindicated in individuals with severe hepatic impairment, those receiving HIV medications, those with prior adverse reactions to similar drugs, or pre-existing osteoporosis. Consult your doctor before use during pregnancy or lactation. Alcohol consumption should be avoided due to its acid-stimulating effect. Refrain from operating machinery or driving if dizziness or somnolence develops.
Uses of Cyra 20mg Tablet
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Cyra 20mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Administer Cyra 20mg Tablet on an empty stomach.
Common Side effects of Cyra 20mg Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Cyra 20mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 20mg Cyra Tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Cyra 20mg Tablet works:
Each Cyra 20mg tablet contains a proton pump inhibitor that lessens stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Use caution when drinking alcohol while taking Cyra 20mg tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of Cyra 20mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The administration of Cyra 20mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a Cyra 20mg Tablet might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely take Cyra 20mg tablets without requiring any modification to the prescribed dosage.
LiverSAFE IF PRESCRIBED
Cyra 20mg tablets pose no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Cyra 20mg Tablet :
Should you forget a Cyra 20mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing pattern. Never take a double dose.
Facts to Know About Cyra 20mg Tablet
Label | Value |
---|---|
Chemical Category | Benzimidazole Sulfoxide |
Developing Habits | No. |
Treatment Category | Gastrointestinal system |
Actions | PPIs |